Novartis Ag (NVS) Income from Continuing Operations (2009 - 2026)
Novartis Ag's Income from Continuing Operations was $5.28 billion in Q2 2026, up 4.8% from $5.04 billion a year earlier and up 16.8% from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) Income from Continuing Operations (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Novartis Ag's Income from Continuing Operations was $36.15 billion through Jun 30, 2026, down 15.1% year-over-year; for FY2025, it came in at $54.53 billion, up 8.4% from FY2024.
- Income from Continuing Operations has now increased for three consecutive years, with a five-year compound annual growth rate of 46.5% (FY2020 to FY2025).
- In earlier years, Income from Continuing Operations was $50.32 billion in FY2024 (+10.7%), $45.44 billion in FY2023 (+7.7%), $42.21 billion in FY2022 (-1.3%) and $42.78 billion in FY2021 (+430.1%).
- Quarterly Income from Continuing Operations has moved between $2.39 billion (Q2 2022) and $21.89 billion (Q4 2025) over five years.
- Compared with a year earlier, Income from Continuing Operations was higher in four of the last eight quarters, with an average decline of 12.2%.
- The best year-over-year quarter for Income from Continuing Operations over five years was Q4 2021 (growth of 587.6%); the worst was Q3 2025 (a decline of 65.2%).
- Per Business Quant data, NVS's Income from Continuing Operations in the three quarters before Q2 2026 was $4.52 billion (Q1 2026), $21.89 billion (Q4 2025) and $4.46 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | -246.00 Mn |
| 10 | Vertex Pharmaceuticals | 126.70 Bn | 98.70 Bn | 2.84 Bn | 1.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.26 Bn |
| Mar 31, 2026 | 4.52 Bn |
| Dec 31, 2025 | 4.03 Bn |
| Sep 30, 2025 | 4.46 Bn |
| Jun 30, 2025 | 4.02 Bn |
| Mar 31, 2025 | 5.21 Bn |
| Dec 31, 2024 | 2.82 Bn |
| Sep 30, 2024 | 3.19 Bn |
| Jun 30, 2024 | 3.25 Bn |
| Mar 31, 2024 | 2.69 Bn |
| Dec 31, 2023 | 2.64 Bn |
| Sep 30, 2023 | 1.51 Bn |
| Jun 30, 2023 | 2.27 Bn |
| Mar 31, 2023 | 2.15 Bn |
| Dec 31, 2022 | 1.32 Bn |
| Sep 30, 2022 | 1.33 Bn |
| Jun 30, 2022 | 1.70 Bn |
| Mar 31, 2022 | 3.12 Bn |
| Dec 31, 2021 | 17.60 Bn |
| Sep 30, 2021 | 3.70 Bn |
API Access
Novartis Ag Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();